Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Cancer Investigation
|
January 1, 1989
Cochleovestibular toxicity related to dichloromethotrexate
L Golden, J D Ahlgren, J Kattah, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 19, 2018
Potentiating KCC2 activity is sufficient to limit the onset and severity of seizures
Yvonne E Moore, Tarek Z Deeb, Heramb Chadchankar, et al.
Neurosurgery
|
April 1, 1987
Magnetic resonance imaging and intraoperative neurosonography in syringomyelia
J E Wilberger, J C Maroon, E R Prostko, et al.
Trends in Neurosciences
|
August 15, 2017
Seizing Control of KCC2: A New Therapeutic Target for Epilepsy
Yvonne E Moore, Matt R Kelley, Nicholas J Brandon, et al.
British Journal of Pharmacology
|
July 12, 2011
The 5-HT3B subunit affects high-potency inhibition of 5-HT3 receptors by morphine
Daniel T Baptista-Hon, Tarek Z Deeb, Nidaa A Othman, et al.
Nature Neuroscience
|
May 3, 2011
NMDA receptor activity downregulates KCC2 resulting in depolarizing GABAA receptor-mediated currents
Henry H C Lee, Tarek Z Deeb, Joshua A Walker, et al.
The Journal of Biological Chemistry
|
June 7, 2013
The minimum M3-M4 loop length of neurotransmitter-activated pentameric receptors is critical for the structural integrity of cytoplasmic portals
Daniel T Baptista-Hon, Tarek Z Deeb, Jeremy J Lambert, et al.
Channels (Austin, Tex.)
|
November 16, 2011
Hyperpolarizing GABAergic transmission depends on KCC2 function and membrane potential
Tarek Z Deeb, Henry H C Lee, Joshua A Walker, et al.
The Journal of Physiology
|
November 26, 2009
A conserved cysteine residue in the third transmembrane domain is essential for homomeric 5-HT3 receptor function
Dai-Fei Wu, Nidaa A Othman, Douglas Sharp, et al.
Neuropharmacology
|
April 26, 2016
Compromising KCC2 transporter activity enhances the development of continuous seizure activity
Matthew R Kelley, Tarek Z Deeb, Nicholas J Brandon, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Cancer Investigation
|
January 1, 1989
Cochleovestibular toxicity related to dichloromethotrexate
L Golden, J D Ahlgren, J Kattah, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 19, 2018
Potentiating KCC2 activity is sufficient to limit the onset and severity of seizures
Yvonne E Moore, Tarek Z Deeb, Heramb Chadchankar, et al.
Neurosurgery
|
April 1, 1987
Magnetic resonance imaging and intraoperative neurosonography in syringomyelia
J E Wilberger, J C Maroon, E R Prostko, et al.
Trends in Neurosciences
|
August 15, 2017
Seizing Control of KCC2: A New Therapeutic Target for Epilepsy
Yvonne E Moore, Matt R Kelley, Nicholas J Brandon, et al.
British Journal of Pharmacology
|
July 12, 2011
The 5-HT3B subunit affects high-potency inhibition of 5-HT3 receptors by morphine
Daniel T Baptista-Hon, Tarek Z Deeb, Nidaa A Othman, et al.
Nature Neuroscience
|
May 3, 2011
NMDA receptor activity downregulates KCC2 resulting in depolarizing GABAA receptor-mediated currents
Henry H C Lee, Tarek Z Deeb, Joshua A Walker, et al.
The Journal of Biological Chemistry
|
June 7, 2013
The minimum M3-M4 loop length of neurotransmitter-activated pentameric receptors is critical for the structural integrity of cytoplasmic portals
Daniel T Baptista-Hon, Tarek Z Deeb, Jeremy J Lambert, et al.
Channels (Austin, Tex.)
|
November 16, 2011
Hyperpolarizing GABAergic transmission depends on KCC2 function and membrane potential
Tarek Z Deeb, Henry H C Lee, Joshua A Walker, et al.
The Journal of Physiology
|
November 26, 2009
A conserved cysteine residue in the third transmembrane domain is essential for homomeric 5-HT3 receptor function
Dai-Fei Wu, Nidaa A Othman, Douglas Sharp, et al.
Neuropharmacology
|
April 26, 2016
Compromising KCC2 transporter activity enhances the development of continuous seizure activity
Matthew R Kelley, Tarek Z Deeb, Nicholas J Brandon, et al.
Page
of 5